LDX - positive quarterly. Unaudited revenue of $1.7M up 55% from previous quarter. $5Million has been received from Hologic deal. Expecting cash flow positive from Hologic deal IP payments alone. $200K in direct product sales in December alone. Last FY was $300K.
